Lonafarnib in Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Lonafarnib
Sponsor: George Sledge
Collaborators: Schering-Plough|Hoosier Cancer Research Network